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A B ST R AC T  
 
Aim: Irritable Bowel syndrome (IBS) is a common gastrointestinal disease worldwide with a broad 
spectrum of symptoms. In present retrospective study, we aimed to compare mean platelet volume to 
platelet ratio (MPR) and red cell distribution width to platelet ratio (RPR) values of IBS patients to 
those of healthy subjects.  
Methods: Patients whom followed up in internal medicine clinic of our institution between 2014 
January to 2018 January were enrolled to the study. IBS subjects divided into constipation dominant 
or diarrhea dominant IBS groups. Healthy individuals visited our outpatient clinics for a check-up 
were enrolled as control group.  
Results: Median MPR of the constipation IBS, diarrhea IS and control groups were 0,034 (0,02-0,06), 
0,034 (0,02-0,06), and 0,028 (0,01-0,05), respectively. The difference between groups was 
statistically significant (p=0.004). 
Conclusion: We think that elevated MPR in a patient with typical symptoms of IBS could be helpful 
in the diagnosis of the disease. Therefore, we suggest automatic calculation of MPR in hemogram 
assays.  
Keywords: Irritable bowel syndrome; mean platelet volume to platelet ratio; inflammation; red cell 
distribution width to platelet ratio.             
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Introduction 
Irritable Bowel syndrome (IBS) is a common 
gastrointestinal disease worldwide with a 
broad spectrum of symptoms [1]. Despite it is 
a common disorder, only a few rate of the 
victims seek medical attention. Symptoms of 
the disease is usually mild, however, could be 
as serious as that deteriorating quality of life.  
Recent studies focused on the role of 
inflammation in the course of IBS [2,3]. 
Indeed, IBS was related with inflammatory 
markers in various studies [4,5]. Novel 
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inflammatory markers, derived from 
hemogram, platelet volume to platelet ratio 
(MPR) and red cell distribution width to 
platelet ratio (RPR) have been proposed to be 
associated with inflammatory conditions [6-
10]. 
In present retrospective study, we aimed to 
compare MPR and RPR values of IBS patients 
to those of healthy subjects. 
 
Methods 
Patients whom followed up in internal 
medicine clinic of our institution between 2014 
January to 2018 January were enrolled to the 
study. IBS subjects divided into constipation 
dominant or diarrhea dominant IBS groups. 
Subjects with active inflammatory or 
infectious diseases, malignancy, or pregnancy 
were excluded. Participants whom on 
treatment with medicines that may affect 
platelet functions (i.e. aspirin) were not 
enrolled to the study. Healthy individuals 
visited our outpatient clinics for a check-up 
were enrolled as control group.  
Age, gender, subtype of IBS (either 
constipation dominant or diarrhea dominant), 
and laboratory parameters, such as white blood 
cell count (WBC), hemoglobin (Hb), 
hematocrit (Htc), mean corpuscular volume 
(MCV), red cell distribution width (RDW), 
platelet count (plt), mean platelet volume 
(MPV), were obtained from database and 
patient files of the institution. The MPR value 
calculated by dividing of MPV by plt. 
Similarly, RPR was calculated by division of 
RDW by plt.  
Data were analyzed with SPSS software, SPSS 
15.0 for Windows, IBM, Co, Chicago, IL, 
USA). Distribution of the study parameters 
were analyzed with Kolmogov-Smirnov test. 
Variables with homogenous distribution were 
compared with One Way ANOVA test and 
expressed as mean ± standard deviation. 
Variables with non-homogenous distribution 
were compared with Kruskall-Wallis test and 
expressed as median (min-max). Categorical 
variables were compared with X2 test. 
Statistical significance was set on a p value 
lower than 0.05.  
 
Results 
Study population was of 145 subjects; 53 in 
constipation IBS, 29 in diarrhea IBS and 63 in 
control groups. Mean age of the constipation 
IBS, diarrhea IBS and control groups were 40 
± 16 years, 44 ± 12 years and 39 ± 10 years, 
respectively. Mean age of the study groups was 
not statistically different among study groups 
(p=0.25).  
There were 14 (26%) men and 39 (74%) 
women in constipation IBS group, 14 (48%) 
men and 15 (52%) women in diarrhea IBS 
group, and 23 (37%) men and 40 (63%) 
women in control group. Gender of the 
subjects in constipation IBS, diarrhea IBS and 
control groups was not statistically different 
(p=0.13).  
There were no significant difference between 
study groups in terms of Hb (p=0.49), Htc 
(p=0.25), WBC (p=0.55), MCV (p=0.07) and 
plt (p=0.67).  
Median MPR of the constipation IBS, diarrhea 
IS and control groups were 0,034 (0,02-0,06), 
0,034 (0,02-0,06), and 0,028 (0,01-0,05), 
respectively. The difference between groups 
was statistically significant (p=0.004). 
However, there was no significant difference 
in RPR values of the study groups, 
constipation IBS, diarrhea IBS and controls 
(p=0.20).   
 
Discussion 
Important results of present study showed that 
patients with IBS have higher MPR values 
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compared to healthy controls. Effect of the IBS 
in MPR was independent from the type of IBS 
(constipation or diarrhea pre-dominant). On 
the other hand, RPR was not associated with 
either constipation or diarrhea dominant IBS.  
Several studies in literature suggested the 
relation between MPR and inflammatory 
conditions. Authors used an index containing 
MPV and platelet count in a study in cancer 
patients and found that platelet count and MPV 
index, as a simple and inexpensive test, was 
more effective prognostic factor than  and is 
considered a more effective prognostic factor 
than other prognostic indices in patients with 
oral squamous cell carcinoma [11]. Not only 
squamous cell carcinoma but also other types 
of cancers were associated with MPR, too. Cho 
et al studied MPR in patients with 
hepatocellular carcinoma and found that 
increased MPR was associated with higher 
hepatocellular carcinoma risk [12]. Their 
results were suggested by Iida et al in a more 
recent study, which proposed MPR as an 
independent risk factor for liver cirrhosis [13]. 
Both cancer and cirrhosis are conditions 
associated with inflammatory burden. 
Therefore, elevated MPR in IBS patients can 
be explained via inflammation hypothesis.  
Possible mechanism of increased MPR in IBS 
could be explained by that inflammatory 
situations may induce platelet production in 
bone marrow and cause releasing of larger 
platelets. Since platelets produced by 
megakaryocytes become enlarged, number of 
platelets produced from a megakaryocyte 
might be decreased. Thus, elevated MPV and 
decreased platelet count make higher MPR.  
The RPR has been introduced as a novel 
marker of inflammation. It has been supposed 
as an independent predictor of mortality in 
patients with severe burn [14]. However, there 
are conflicting results about RPR in literature. 
RPR of patients with premature ovarian 
insufficiency was not statistically different 
from the RPR of healthy control subjects in a 
study by Ilhan et al. [15]. Similarly, we could 
not found an association between IBS types 
and RPR in present study. Therefore, we think 
that more studies are needed to observe 
whether RPR and inflammatory conditions 
were associated.   
There are two limitations in our report; 
retrospective design and small study cohort. 
These limitations make the results of present 
report difficult to interpret in current medical 
knowledge. However, to the best of our 
knowledge, this is the first study in literature 
that reported association between IBS and 
MPR.  
In conclusion, we think that elevated MPR in a 
patient with typical symptoms of IBS could be 
helpful in the diagnosis of the disease. 
Therefore, we suggest automatic calculation of 
MPR in hemogram assays. 
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